Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.

The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.

Zhitong FinanceAug 7 01:50 ET

Little Excitement Around CANbridge Pharmaceuticals Inc.'s (HKG:1228) Revenues As Shares Take 28% Pounding

Simply Wall StAug 6 18:16 ET

CANbridge Pharmaceuticals Inc.'s (HKG:1228) 26% Dip In Price Shows Sentiment Is Matching Revenues

Simply Wall StMay 23 19:11 ET

CANBRIDGE-B: 2023 ANNUAL REPORT

Hong Kong Stock ExchangeApr 30 00:02 ET · Announcements

Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials

MT NewswiresApr 22 22:42 ET

Beihai Kangcheng-B (01228) decided to discontinue development and further testing of CAN008 in the field of glioblastoma

Beihai Kangcheng-B (01228) announced that CAN008 in patients newly diagnosed with glioblastoma based on treatment...

Zhitong FinanceApr 22 10:56 ET